Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D38OHM
|
|||
| Drug Name |
VH3810109
|
|||
| Synonyms |
GSK3810109A
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62] | Phase 2 | [1] | |
| Company |
GlaxoSmithKline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05291520) A Phase 1, Open-Label, Single-Dose Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, GSK3810109, Administered Either Subcutaneously or Intravenously With Recombinant Human Hyaluronidase PH20 (rHuPH20) to Healthy Adults. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.